Media

Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution, Schirrmacher et al, Biomedicines, 2024

Publication

Methods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients, Van Gool et al, Methods in Cell Biology, 2023

Publication

Dendritic cell vaccination for glioblastoma multiforme patients: has a new milestone been reached? Van Gool et al, Translational Cancer Research, 2023

Publication

Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience, Van Gool et al, Cancers, 2023

Publication

The Application of Evidence-Based Medicine in Individualized Medicine, Van de Vliet et al, Biomedicines, 2023

Publication

Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients, Van Gool et al, Genes & Immunity, 2022

Publication

Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy, Schirrmacher et al, International Journal of Molecular Sciences, 2022

Publication

Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged, Van Gool et al, Cancers, 2021

Publication

Individualized Multimodal Immunotherapy for DIPG: Part of the Game, Van Gool et al, Journal of Immunobiology, 2021

Publication

Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience, Van Gool et al, Medicines, 2020

Publication

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death, Galluzzi et al, Journal for ImmunoTherapy of Cancer, 2020

Publication

Biological material collection to advance translational research and treatment of children with CNS tumours: position paper from the SIOPE Brain Tumour Group, Rutkowski et al, Lancet Oncology, 2018

Publication